Recovery from multiple myeloma leads to a renewed sense of purpose and determination, with hope found in small victories. The ...

Infection risk remains a prominent clinical concern for patients with multiple myeloma (MM), even with the advent of modern, ...

Bispecific antibody therapy is transforming cancer treatment, especially in multiple myeloma, with ongoing studies exploring ...

On the basis of the data presented from the MM-009 and MM-010 trials, FDA approved lenalidomide for use in combination with dexamethasone in patients with MM who have received one prior therapy ...

They report a concerning relationship between micro and nanoplastic (MNP) concentrations in damaged tissues and links with multiple health ... particles detected in skin, arteries, veins, thrombi ...

Purpose: The pharmacology, clinical use, adverse effects, dosage and administration, and cost of lenalidomide in the treatment of multiple myeloma ... of destructive bony lesions, and renal ...

DARZALEX FASPRO ® is a prescription medicine used to treat adult patients with multiple ... myeloma. · DARZALEX FASPRO ® will be given to you by your healthcare provider as an injection under ...

Multiple myeloma and AL amyloidosis are conditions linked to plasma cells in the bone marrow. Multiple myeloma (MM) is a cancer affecting the plasma cells, which are mostly in the bone marrow.